• Open Account

Welcure Drugs & Pharmaceuticals Ltd

Small Cap | Pharmaceuticals
₹ 0.27 0(0%)
Last updated: 17-Mar-2026 , 16:00:00

Welcure Drugs & Pharmaceuticals Ltd Live Price Chart

Performance

Low: ₹0.26 High: 0.27
Previous Close ₹ 0.27
High ₹ 0.27
Volume 6076235
52W Range ₹ 0.26 - ₹ 1.44
Open ₹ 0.26
Low ₹ 0.26
Market Cap ₹ 66 Cr
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges

Welcure Drugs & Pharmaceuticals Ltd Technicals

Current Price
₹ 0.27 0 (0%)
EMASMA
20 Day ₹ 0.304
50 Day ₹ 0.351
100 Day ₹ 0.444
200 Day ₹ 0.565
20 Day ₹ 0.311
50 Day ₹ 0.342
100 Day ₹ 0.438
200 Day ₹ 0.691

Welcure Drugs & Pharmaceuticals Ltd Fundamentals

ROCE 17.526
P/E Ratio 0.930
P/B Ratio 0.250
Industry P/E 0.250
Debt to Equity 39.705
ROE 25.600
EPS 0.290
Dividend Yield 0.000
Book Value 1.086
Face Value 1.000

Welcure Drugs & Pharmaceuticals Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 26.4599 0.0939 0.2371 0.105 0.1335599
Total Expenses 23.6798 0.2687 0.1354 0.0814207 0.0784122
Profit After Tax 2.1701 -0.1748 0.1017 0.0235793 0.0551477

Welcure Drugs & Pharmaceuticals Ltd Shareholding Pattern

Promoter Holdings 0.000 %
FIIs 0.000 %
DIIs 0.000 %
MutualFund 0.000 %
Retail 94.407 %
Others - 5.593 %

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market. The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medici ...

FAQs on Welcure Drugs & Pharmaceuticals Ltd

1. Can I buy Welcure Drugs & Pharmaceuticals Ltd from PL Capital?

Yes, you can invest in Welcure Drugs & Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Welcure Drugs & Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Welcure Drugs & Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Welcure Drugs & Pharmaceuticals Ltd pay dividends?

Welcure Drugs & Pharmaceuticals Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Welcure Drugs & Pharmaceuticals Ltd ?

As of 17-Mar-2026 , 16:00:00 the share price for Welcure Drugs & Pharmaceuticals Ltd. is ₹ 0.27 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Welcure Drugs & Pharmaceuticals Ltd ?

The 52-week high and low of Welcure Drugs & Pharmaceuticals Ltd share price is ₹ 0.26 - ₹ 1.44 as of 17-Mar-2026 , 16:00:00 .
App QR Code

Download the PL Capital App

Open Demat Account
×